Moderna, Inc. Is an American pharmaceutical and biotechnology company founded by Noubar Afeyan, Robert S. Langer, Derrick Rossi, Kenneth R. Chien in September 2010. It has its headquarter in Cambridge, Massachusetts, U.S.
It mainly focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to produce an immune response.
Moderna launched its IPO on Dec 6, 2018 under the ticker symbol ‘MRNA’ at a price of $23/share.
Moderna Stock Forecast (Short- and Long-Term)
Here below is aa basic price prediction table: –
| Year | Mid-Year | Year-End |
| 2023 | $ 231 | $ 248 |
| 2024 | $ 277 | $ 305 |
| 2025 | $ 351 | $ 396 |
| 2030 | $ 701 | $ 716 |
| 2034 | $ 845 | $ 868 |
Short-term forecast
- Moderna price prediction 2023: The Moderna price will increase to $231 in the first half of 2023; in the second, it will increase by $17 to complete the year at $248, which is a 25% increase over the present price.
- Moderna price prediction 2024: The price of Moderna in 2024 will begin at $248, rise to $277 in the first six months of the year, and end at $305. That is an increase of 53% from today.
Long-term forecast
- Moderna price prediction 2025: The stock price will increase to $351 in the first half and till the end of year it will increase to $396, which is an increase of 99% from today.
- Moderna price prediction 2030: In the mid of 2030 the price will reach to $701 and with the end of the year the stock price will increase to $716. That is a total increase of 260% from current price.
- Moderna price prediction 2034: The price of the stock will increase to $845 and till the end of the year it will rise to $868. That is 336% from now.
Current stock price of Moderna stock is 199.08 USD.
Factors Affecting Moderna Stock Price
Here below are the main factors that can affect the price of stock.
- Sales: As it is a pharmaceutical company so researching and selling a large number of vaccines is the major revenue generator for the company and just like any other company sales can affect the growth of this company too.
- Competition: As there is competition everywhere in the industry and as being a biotechnology company, it has big competitions with other big pharmaceutical firms. For example- Moderna’s Spikevax (a COVID-19 vaccine) has to face Pfizer.
Is Moderna Stock a Buy Now?
As After a cancer experiment produced promising findings, Moderna’s stock price recently increased. So, you can give it a try if you want as it is expected by the experts that stock will definitely give a better return in near future.
We only offer advice based on our best guesses;therefore, we suggest you conduct your own research before taking any action.
